PMS2 and cervical squamous intraepithelial neoplasia: Based on these, we categorized the 56 cases as follows: EBV group (EBER-positive), no cases (0%); MSI group (MLH1 and PMS2 loss), 5 cases (9%); and CIN/GS group (EBER-negative and MSS), 51 cases (91%).